National Human Genome Research Institute; Notice of Meeting, 49473 [2023-16147]
Download as PDF
<![CDATA[
49473
Federal Register / Vol. 88, No. 145 / Monday, July 31, 2023 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Form name
Type of respondents
PCP Lecture Evaluation (Attachment 3) ...................................................
PCP Final Course Evaluation (Attachment 5) ...........................................
NIH Summer Course in Clinical and Translational Research Course
Evaluation (Attachment 6).
Sabbatical in Clinical Research Management Course Evaluation (Attachment 7).
Ethical and Regulatory Aspects of Clinical Research (Asynchronous/Online) Course (Attachment 8).
Total ....................................................................................................
Dated: July 25, 2023.
Tara A. Schwetz,
Acting Principal Deputy Director, National
Institutes of Health.
[FR Doc. 2023–16184 Filed 7–28–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
ddrumheller on DSK120RN23PROD with NOTICES1
National Human Genome Research
Institute; Notice of Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
Council for Human Genome Research.
This is a hybrid meeting held inperson and virtually and is open to the
public as indicated below. Individuals
who plan to attend in-person or view
the virtual meeting and need special
assistance or other reasonable
accommodations, should notify the
Contact Person listed below in advance
of the meeting. The meeting will be
videocast and can be accessed from
https://www.genome.gov/about-nhgri/
Institute-Advisors/National-AdvisoryCouncil-for-Human-Genome-Research.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
VerDate Sep<11>2014
18:11 Jul 28, 2023
Jkt 259001
Estimated
number of
respondents
Frm 00040
Average
burden per
response
(in hours)
Total
annual
burden
hours
General Public ........................
Healthcare Professionals ........
Students ..................................
General Public ........................
Healthcare Professionals ........
Students ..................................
General Public ........................
Healthcare Professionals ........
250
750
500
250
750
500
250
20
1
1
1
1
1
1
1
1
5/60
5/60
5/60
5/60
5/60
5/60
5/60
5/60
21
63
42
21
63
42
21
2
Healthcare Professionals ........
20
1
5/60
2
Healthcare Professionals ........
Students ..................................
General Public ........................
100
50
100
1
1
1
5/60
5/60
5/60
8
4
8
.................................................
........................
9,790
....................
820
Name of Committee: National Advisory
Council for Human Genome Research.
Date: September 18–19, 2023.
Closed: September 18, 2023, 9:00 a.m. to
10:00 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, National Institutes of Health, 6700B
Rockledge Drive, Suite 1100, Bethesda, MD
20892.
Open: September 18, 2023, 10:30 a.m. to
6:30 p.m.
Agenda: Report of Institute Director and
Institute Staff.
Place: National Human Genome Research
Institute, 6700B Rockledge Drive, Suite 1100,
Bethesda, MD 20892.
Closed: September 19, 2023, 10:00 a.m. to
5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, National Institutes of Health, 6700B
Rockledge Drive, Suite 1100, Bethesda, MD
20892.
Contact Person: Rudy O. Pozzatti, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Human Genome Research
Institute, 6700B Rockledge Drive, Suite 1100,
Rockville, MD 20892, (301) 402–0838,
pozzattr@mail.nih.gov.
Any interested person may file written
comments with the committee within 15
days after the meeting by forwarding the
statement to the Contact Person listed on this
notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.genome.gov/council, where an agenda
and any additional information for the
meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
PO 00000
Number of
responses per
respondent
Fmt 4703
Sfmt 4703
Dated: July 26, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–16147 Filed 7–28–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; Generic Clearance
for NIH Citizen Science and
Crowdsourcing Projects (Office of the
Director)
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30-days of the date of this
publication.
SUMMARY:
Written comments and/or
suggestions regarding the item(s)
contained in this notice, especially
regarding the estimated public burden
and associated response time, should be
directed to the: Office of Management
and Budget, Office of Regulatory Affairs,
OIRA_submission@omb.eop.gov or by
fax to 202–395–6974, Attention: Desk
Officer for NIH.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
ADDRESSES:
E:\FR\FM\31JYN1.SGM
31JYN1
]]>Agencies
[Federal Register Volume 88, Number 145 (Monday, July 31, 2023)]
[Notices]
[Page 49473]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-16147]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Human Genome Research Institute; Notice of Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Advisory
Council for Human Genome Research.
This is a hybrid meeting held in-person and virtually and is open
to the public as indicated below. Individuals who plan to attend in-
person or view the virtual meeting and need special assistance or other
reasonable accommodations, should notify the Contact Person listed
below in advance of the meeting. The meeting will be videocast and can
be accessed from https://www.genome.gov/about-nhgri/Institute-Advisors/National-Advisory-Council-for-Human-Genome-Research.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Council for Human Genome
Research.
Date: September 18-19, 2023.
Closed: September 18, 2023, 9:00 a.m. to 10:00 a.m.
Agenda: To review and evaluate grant applications.
Place: National Human Genome Research Institute, National
Institutes of Health, 6700B Rockledge Drive, Suite 1100, Bethesda,
MD 20892.
Open: September 18, 2023, 10:30 a.m. to 6:30 p.m.
Agenda: Report of Institute Director and Institute Staff.
Place: National Human Genome Research Institute, 6700B Rockledge
Drive, Suite 1100, Bethesda, MD 20892.
Closed: September 19, 2023, 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Human Genome Research Institute, National
Institutes of Health, 6700B Rockledge Drive, Suite 1100, Bethesda,
MD 20892.
Contact Person: Rudy O. Pozzatti, Ph.D., Scientific Review
Officer, Scientific Review Branch, National Human Genome Research
Institute, 6700B Rockledge Drive, Suite 1100, Rockville, MD 20892,
(301) 402-0838, [email protected].
Any interested person may file written comments with the
committee within 15 days after the meeting by forwarding the
statement to the Contact Person listed on this notice. The statement
should include the name, address, telephone number and when
applicable, the business or professional affiliation of the
interested person.
Information is also available on the Institute's/Center's home
page: https://www.genome.gov/council, where an agenda and any
additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human
Genome Research, National Institutes of Health, HHS)
Dated: July 26, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-16147 Filed 7-28-23; 8:45 am]
BILLING CODE 4140-01-P
